Renaissance Technologies’s Sensus Healthcare SRTS Stock Holding History

Renaissance Technologies’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1M	Sell	252,234 -4,800	-2%	-$21.3K	﹤0.01%	2277
2025 Q4	$1.02M	Sell	257,034 -4,100	-2%	-$15.2K	﹤0.01%	2266
2025 Q3	$820K	Buy	261,134 +11,000	+4%	+$43.2K	﹤0.01%	2582
2025 Q2	$1.19M	Sell	250,134 -9,500	-4%	-$44.5K	﹤0.01%	2413
2025 Q1	$1.23M	Sell	259,634 -171,300	-40%	-$997K	﹤0.01%	2276
2024 Q4	$2.98M	Buy	430,934 +21,600	+5%	+$158K	﹤0.01%	1784
2024 Q3	$2.37M	Buy	409,334 +17,800	+5%	+$108K	﹤0.01%	1901
2024 Q2	$2.09M	Buy	391,534 +100,294	+34%	+$461K	﹤0.01%	1861
2024 Q1	$1.11M	Buy	291,240 +492	+0.2%	+$1.78K	﹤0.01%	2427
2023 Q4	$686K	Sell	290,748 -41,525	-12%	-$97.2K	﹤0.01%	2615
2023 Q3	$920K	Sell	332,273 -35,661	-10%	-$109K	﹤0.01%	2363
2023 Q2	$1.16M	Buy	367,934 +91,800	+33%	+$332K	﹤0.01%	2381
2023 Q1	$1.44M	Buy	276,134 +97,400	+54%	+$699K	﹤0.01%	2230
2022 Q4	$1.33M	Sell	178,734 -87,300	-33%	-$787K	﹤0.01%	2358
2022 Q3	$3.33M	Buy	266,034 +52,600	+25%	+$628K	﹤0.01%	1697
2022 Q2	$1.64M	Sell	213,434 -98,700	-32%	-$829K	﹤0.01%	2342
2022 Q1	$3.16M	Buy	312,134 +150,200	+93%	+$1.37M	﹤0.01%	1885
2021 Q4	$1.17M	Buy	161,934 +139,900	+635%	+$766K	﹤0.01%	2532
2021 Q3	$79K	Buy	22,034 +200	+0.9%	+$731	﹤0.01%	3349
2021 Q2	$84K	Buy	21,834 +300	+1%	+$1.13K	﹤0.01%	3374
2021 Q1	$82K	Buy	21,534 +3,100	+17%	+$12.7K	﹤0.01%	3232
2020 Q4	$71K	Buy	18,434 +5,800	+46%	+$17.7K	﹤0.01%	3298
2020 Q3	$32K	Buy	12,634 +1,400	+12%	+$3.94K	﹤0.01%	3305
2020 Q2	$34K	Buy	+11,234	New	+$29.3K	﹤0.01%	3360
2018 Q4	–	Sell	-48,100	Closed	-$403K	–	3602
2018 Q3	$403K	Buy	48,100 +20,612	+75%	+$149K	﹤0.01%	2920
2018 Q2	$200K	Buy	27,488 +16,088	+141%	+$105K	﹤0.01%	3076
2018 Q1	$67K	Buy	11,400 +1,100	+11%	+$6.21K	﹤0.01%	3290
2017 Q4	$53K	Sell	10,300 -16,739	-62%	-$90.7K	﹤0.01%	3259
2017 Q3	$135K	Buy	+27,039	New	+$133K	﹤0.01%	3063

Other funds holding SRTS

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

GWM

Greenline Wealth Management Boca Raton, Florida $122M AUM

NSIM

North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Renaissance Technologies's SRTS Position: Q1 2026 in Review

Renaissance Technologies reduced its Sensus Healthcare (SRTS) stake by 1.9% in Q1 2026, selling an estimated $21.3K and leaving 252,234 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Renaissance Technologies first reported a position in SRTS in Q3 2017 and has held it in 29 quarters since. The position peaked at $3.33M in Q3 2022. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

Renaissance Technologies held 252,234 shares of Sensus Healthcare worth $1M as of Q1 2026.
Renaissance Technologies sold 4,800 Sensus Healthcare shares in Q1 2026, an estimated $21.3K.
Sensus Healthcare made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2277 holding.
Renaissance Technologies first reported a position in Sensus Healthcare in Q3 2017 and has held it in 29 quarters since.
Renaissance Technologies's Sensus Healthcare position peaked at $3.33M in Q3 2022.
41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.